The order eases restrictions on psychedelic drugs like ibogaine to spur research on using them for medical purposes.
The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help treat post-traumatic stress disorder.
By Kamal Choudhury April 20 (Reuters) - Shares of psychedelic drug developers rose on Monday after U.S. President Donald ...
Trump ordered faster approval of ibogaine for PTSD, backing research and funding that could expand access to psychedelic-based treatments.
WASHINGTON (AP) — President Donald Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat ...
President Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and conservative ...